1 / 24

Hepatitis B 101

Hepatitis B 101 . Erin M. Bachus Adult Immunization Coordinator Communicable Disease Prevention Unit San Francisco Department of Public Health. Learning Objectives. By the end of this presentation, participants will be able to: Explain the differences between Hepatitis A, B, and C

sherine
Download Presentation

Hepatitis B 101

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hepatitis B 101 Erin M. Bachus Adult Immunization Coordinator Communicable Disease Prevention Unit San Francisco Department of Public Health

  2. Learning Objectives • By the end of this presentation, participants will be able to: • Explain the differences between Hepatitis A, B, and C • Discuss the vaccination schedule for Hepatitis A and Hepatitis B • Understand the basic serological testing methods for Hepatitis B

  3. Hepatitis A • Transmission • Fecal-Oral transmission • Self-Limiting - does not become chronic • Infection = Protection • Who is at risk? • Men who have Sex with Men, • Travelers • all areas of the world except Canada, Western Europe and Scandinavia, Japan, New Zealand, and Australia) • Contacts of infected persons • Users of illegal drugs • Highly effective vaccine – 2 dose series, separated by 6 months

  4. Hepatitis C • Transmission • Blood transmission • Transmission through sex is possible, but not probable • Can lead to chronic illness • Who is at risk? • Users of illegal drugs • Recipients of clotting factors before 1987 • Infants of infected mothers • Hemodialysis patients • NO vaccine

  5. Hepatitis B • Transmission • Via blood and body fluids • Hep B is 100x more infections than HIV • Who is at risk? • Persons with multiple sex partners or diagnosis of a sexually transmitted disease • Men who have sex with men • Sex contacts of infected persons • Injection-drug users • Persons born in HBV endemic areas (see map) • Household contacts of chronically infected persons • Infants born to infected mothers • Infants/children of immigrants from areas with high rates of HBV infection • Health care and public safety workers with exposure to blood • Hemodialysis patients

  6. Hepatitis B Endemic Countries

  7. Hepatitis B • Symptoms • Experienced by 30% of people • May include: • Jaundice • Fatigue • Abdominal pain • Anorexia • Hep B can cause lifelong (chronic) infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death • Serologic testing and lifelong monitoring of chronically infected persons is essential for the prevention of severe liver disease

  8. Prevention of Hepatitis A, B, and C • Having protected sex • Avoiding drug use or using harm reduction methods while using them • i.e. not sharing needles • Good hand washing • Number one – Get vaccinated! • No vaccine for hep C

  9. Rates of Hepatitis in SF

  10. Vaccines • Hepatitis A • 2 dose series • Each dose separated by 6 months • Incredibly effective • 95-97% of people are fully protected after 1 dose! • Hepatitis B • 3 dose series • Schedule: 0,1,4-6 months • Combination hep A/hep B • Called Twinrix • 3 dose series • Schedule: 0,1,6 months *Minimum intervals only! Vaccine series never need to be restarted!*

  11. Hepatitis B and Chronic Infection • < 1% of general population develops chronic infection • Chronic infection risk decreases with age • Up to 90% of infants infected at birth • 30-50% of those infected between age 1 and 5 years • 5% of those infected as adults • Persons born in endemic countries have a much higher risk of chronic infection • 1 in 10 people! • Not related to genetics • 1 in 4 of those with chronic infection will die prematurely from cirrhosis or liver cancer • San Francisco is working on preventing this!!

  12. Serologic Testing for Hep B • Blood test used to detect: • HBsAg – determines if an active infection is present • Anti-HBs – determines if a person has immunity to the disease, either from previous infection or vaccination • Many free or low-cost places in SF to go • Very important! • Saves lives • As many as 1 in 10 Asians are infected and many of them are unaware due to a lack of symptoms

  13. MMWR Recommendations and Reports 9.19.08 • “Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection” • First ever published screening recommendations for chronic hepatitis B • Who should be tested? • Persons born in geographic regions with HBsAg prevalence of >2%. • Persons with behavioral exposures to HBV • Men who have sex with men • Users of illegal drugs • Persons receiving cytotoxic or immunosuppressive therapy • Persons with liver disease of unknown etiology

  14. What are we doing in SF?

  15. SF Hep B Free • Campaign goals • To create public and healthcare provider awareness about the importance of testing and vaccinating API for hepatitis B • To promote routine hepatitis B testing and vaccination within the primary care medical community • To ensure access to treatment for chronically infected individuals • Strategies • Public Awareness • Screening • Vaccination • Treatment / Follow-up www.sfhepbfree.org

  16. SF Hep B Free • An innovative collaboration of public/private partners • Unmatched across the country • Galvanized multiple constituents for sustainability • Effective response to major local public health concern • Partners encompass entire health care sector, universities, legislators, foundations, CBOs, and news agencies www.sfhepbfree.org

  17. Active Partners

  18. Testing & vaccination sites

  19. Provider Education • Study population • 196 PCP attendees of a university-based CME primary care Internal Medicine conferences (spring 2007) • 78% response rate • Only 45% of clinicians correctly chose HBsAg as the screening test of choice for CHB • 46% were unaware that HBV can be controlled by medications • Overestimated the relative prevalence of CHB: said other at risk groups have a higher prevalence than Chinese • HIV (40%), MSM (41%), IVDU (60%)

  20. Provider Education

  21. Hep B Free Highlights • 2007 • Board of Supervisors passes Fiona Ma’s resolution to test & vaccinate all API residents • Resolution endorsed by Health Commission. No funds allocated • Interagency Steering group established to create SF Hep B Free campaign • Planning Group with all key stakeholders established • Bus ads featuring Mayor Newsom & Assemblywoman Ma run throughout city • SFSU and CCSF commit to on campus testing & vaccination campaigns • Eight CME events reach 230 primary care providers • Seven new, low cost, public access testing & vaccination sites available • 2008 • Be a Hero public awareness campaign runs for 3 consecutive months • Co-sponsored four clinician education events • 32 organizations continue to actively participate in campaign • Five working groups contribute to success of campaign • Educated 220 staff at 15 API Health Parity Coalition agencies about hepatitis B • Screened over 4000 people for chronic hepatitis B • Raised over $400,000 in grant funds from for public awareness, evaluation, and staff support • Replication of Hep B Free begun in multiple communities • Diagnostic flowchart developed and distributed

  22. Public awareness campaign launched in SF in September 2008 • Kickoff with gala fundraising dinner and press conference unveiling first ever screening guidelines for hepatitis B • Ran for 3 consecutive months • Billboard, Muni, Print, Radio, and TV Ads

  23. Questions? • My contact information • Erin Bachus, Adult Immunization Coordinator San Francisco Dept of Public Health (415) 554-2830 erin.bachus@sfdph.org

More Related